Man Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-37,367
| Closed | -$5.09M | – | 2014 |
|
|
2020
Q3 | $5.09M | Buy |
37,367
+2,964
| +9% | +$315K | 0.02% | 806 |
|
|
2020
Q2 | $3.32M | Buy |
34,403
+24,309
| +241% | +$2.03M | 0.02% | 852 |
|
|
2020
Q1 | $473K | Buy |
+10,094
| New | +$647K | ﹤0.01% | 1290 |
|
|
2019
Q4 | – | Sell |
-25,615
| Closed | -$1.33M | – | 1965 |
|
|
2019
Q3 | $1.33M | Buy |
+25,615
| New | +$1.36M | 0.01% | 1362 |
|
|
2019
Q2 | – | Sell |
-18,059
| Closed | -$939K | – | 2077 |
|
|
2019
Q1 | $939K | Sell |
18,059
-115,357
| -86% | -$5.31M | ﹤0.01% | 1596 |
|
|
2018
Q4 | $6.52M | Sell |
133,416
-18,237
| -12% | -$1M | 0.03% | 630 |
|
|
2018
Q3 | $9.89M | Buy |
151,653
+45,880
| +43% | +$2.7M | 0.04% | 629 |
|
|
2018
Q2 | $5.25M | Buy |
105,773
+21,386
| +25% | +$1.04M | 0.02% | 924 |
|
|
2018
Q1 | $4.12M | Buy |
+84,387
| New | +$4.39M | 0.02% | 953 |
|
Man Group's MYOK Position: Q4 2020 in Review
Man Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 37,367 shares — an estimated $5.09M sold.
Man Group first reported a position in MYOK in Q1 2018 and held it in 9 quarters. The position peaked at $9.89M in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Man Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Man Group sold 37,367 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.09M.
- Man Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
- Man Group's MyoKardia, Inc. Common Stock position peaked at $9.89M in Q3 2018.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Man Group's 13F filing for Q4 2020, filed 16 Feb 2021.